Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Gins2em1flox/Cya
Common Name:
Gins2-flox
Product ID:
S-CKO-09981
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gins2-flox
Strain ID
CKOCMP-272551-Gins2-B6J-VA
Gene Name
Gins2
Product ID
S-CKO-09981
Gene Alias
2210013I18Rik; 4833427B12Rik; Pfs2; Psf2
Background
C57BL/6JCya
NCBI ID
272551
Modification
Conditional knockout
Chromosome
8
Phenotype
MGI:1921019
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Gins2em1flox/Cya mice (Catalog S-CKO-09981) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000034278
NCBI RefSeq
NM_178856
Target Region
Exon 3
Size of Effective Region
~1.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
GINS2, a subunit of DNA helicase, is crucial for maintaining genomic stability as it contributes to DNA replication processes [2,5]. It is involved in various signaling pathways, such as STAT3/MYC, EGR1/ECT2, PTP4A1/p53, ERK/MAPK, PI3K/Akt, and STAT, influencing cell growth, apoptosis, and epithelial-mesenchymal transition (EMT) in different biological contexts [1,2,3,4,7,8].

GINS2 is highly expressed in several cancers including osteosarcoma, gliomas, colon cancer, pancreatic cancer, HNSCC, and NSCLC, promoting tumorigenesis, cell proliferation, and inhibiting apoptosis. For example, in osteosarcoma, GINS2 knockdown hindered cell growth and induced apoptosis both in vitro and in vivo, and reduced the activity of the MYC signaling pathway [1]. In gliomas, GINS2 regulated temozolomide chemosensitivity via the EGR1/ECT2 axis [2]. In colon cancer, GINS2 knockdown inhibited cell proliferation and increased apoptosis through the PTP4A1/p53 pathway [3]. In pancreatic cancer, GINS2 promoted EMT via the ERK/MAPK signaling pathway [4]. In HNSCC, GINS2 promoted cell proliferation and inhibited apoptosis by altering RRM2 expression [6]. In NSCLC, GINS2 promoted cell proliferation, migration, invasion, and EMT via the PI3K/Akt and MEK/ERK signaling pathways [7]. In contrast, in lung cancer, GINS2 knockdown inhibited cell proliferation, suggesting it may act as a tumor suppressor through the STAT signaling pathway [8]. Also, in intervertebral disk degeneration, GINS2 was downregulated in the peripheral blood, and overexpressing it promoted the proliferation and migration of nucleus pulposus cells [9]. In hepatocellular carcinoma, GINS2-overexpressed patients had poorer survival, and it was associated with cell cycle, DNA replication, and immune cell infiltration [10].

In conclusion, GINS2 plays diverse roles in different biological processes and diseases. Its overexpression in many cancers promotes tumor-related phenotypes, while in some cases like lung cancer, it may have a tumor-suppressive role. The study of GINS2 through gene-knockout or conditional-knockout models in mice (although not specifically detailed in the references but a valuable approach in general) could further clarify its functions and mechanisms in these disease areas, potentially providing new therapeutic targets for cancer and other diseases.

References:
1. Ren, Bingkai, Zheng, Yibin, Nie, Lizhong, Wei, Jingdu, Yang, Dong. 2023. GINS2 Promotes Osteosarcoma Tumorigenesis via STAT3/MYC Axis. In Journal of oncology, 2023, 8454142. doi:10.1155/2023/8454142. https://pubmed.ncbi.nlm.nih.gov/36873736/
2. He, Hua, Liang, Lu, Jiang, Shiyao, Jiang, Yiqun, Cong, Li. 2024. GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. In Cell death & disease, 15, 205. doi:10.1038/s41419-024-06586-w. https://pubmed.ncbi.nlm.nih.gov/38467631/
3. Hu, Hao, Ye, Lina, Liu, Zhe. 2022. GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1. In Molecular medicine reports, 25, . doi:10.3892/mmr.2022.12633. https://pubmed.ncbi.nlm.nih.gov/35137928/
4. Huang, Longping, Chen, Si, Fan, Haijun, Chen, Chuanping, Sheng, Weiwei. 2020. GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling. In Cancer gene therapy, 28, 839-849. doi:10.1038/s41417-020-0206-7. https://pubmed.ncbi.nlm.nih.gov/32747685/
5. Nabais Sá, Maria J, Miller, Kerry A, McQuaid, Mary, de Brouwer, Arjan P M, Oliveira, Jorge. 2021. Biallelic GINS2 variant p.(Arg114Leu) causes Meier-Gorlin syndrome with craniosynostosis. In Journal of medical genetics, 59, 776-780. doi:10.1136/jmedgenet-2020-107572. https://pubmed.ncbi.nlm.nih.gov/34353863/
6. Wang, Tianxiang, Qian, Luxi, Zhang, Pingchuan, Yin, Li, He, Xia. . GINS2 promotes the progression of human HNSCC by altering RRM2 expression. In Cancer biomarkers : section A of Disease markers, 40, 171-184. doi:10.3233/CBM-230337. https://pubmed.ncbi.nlm.nih.gov/38517779/
7. Liu, Xiangli, Sun, Lei, Zhang, Song, Zhang, Shuguang, Li, Wenya. 2019. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. In Journal of cellular physiology, 235, 7747-7756. doi:10.1002/jcp.29381. https://pubmed.ncbi.nlm.nih.gov/31681988/
8. Sun, Dianmin, Zong, Yuanyuan, Cheng, Jinling, Xing, Ligang, Yu, Jinming. 2021. GINS2 attenuates the development of lung cancer by inhibiting the STAT signaling pathway. In Journal of Cancer, 12, 99-110. doi:10.7150/jca.46744. https://pubmed.ncbi.nlm.nih.gov/33391406/
9. Jiang, Haitao, Sun, Hailang, Dai, Jian, Zhang, Cheng, Tang, Xiaoming. 2022. GINS2 Is Downregulated in Peripheral Blood of Patients with Intervertebral Disk Degeneration and Promotes Proliferation and Migration of Nucleus Pulposus Cells. In Computational and mathematical methods in medicine, 2022, 1986348. doi:10.1155/2022/1986348. https://pubmed.ncbi.nlm.nih.gov/36092790/
10. Li, Zuyin, Song, Guohe, Guo, Dezhen, Wang, Xiaoliang, Wang, Yupeng. 2022. Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma. In Journal of Cancer, 13, 610-622. doi:10.7150/jca.53841. https://pubmed.ncbi.nlm.nih.gov/35069907/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest